Alzheimer's Association (AAIC) conference presentation by Cassava Sciences: Encouraging Interim Results at 9 Months from an Open-Label Study of Simufilam in Patients with Alzheimer’s Disease

Alzheimer's Association (AAIC) conference presentation by Cassava Sciences: Encouraging Interim Results at 9 Months from an Open-Label Study of Simufilam in Patients with Alzheimer’s Disease: https://ift.tt/3j1pvzx Read more... https://ift.tt/3iZHR3S